Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids offers a revolutionary investigation of the complicated relationships between cancer metabolism and three crucial factors: the gut microbiota, reactive oxygen species (ROS), and the dysregulation of the short chain fatty acid (SCF) complex. This book adopts a thorough and interdisciplinary approach to untangle the intricate interactions between these components, providing fresh perspectives that fundamentally alters the understanding of cancer biology and therapy. In 14 chapters.
Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids provides a thorough investigation of the metabolic changes that occur inside cancer cells, illuminating how these changes promote tumour survival and progression, from introduction to future aspects. Researchers in cancer research, and gut microbiology will find this an essential reference.
- Creates new opportunities for focused therapies and patient-specific therapy plans by exploring the roles of the gut microbiota, ROS, and SCF dysregulation in cancer metabolism
- Discusses in-vitro, ex-vivo, and animal models used to examine the effects of probiotics and their metabolites in cancer care
- Focuses on cutting-edge research on probiotics and their byproducts treatments in oncogene downregulation, autophagy induction, kinase inhibition, tumour suppressor reactivation, and metastasis prevention
Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.
Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.
Goutam Rath is a professor in the Department of Pharmaceutics at the School of Pharmaceutical Sciences, Siksha 'O' Anusandhan, Bhubaneswan, India. A leading researcher in nanotechnology-based platforms for targeted drug and bioactive delivery, he has earned international recognition for his scientific contributions. He has consistently ranked among the world’s top 2% scientists, as listed by Stanford University, for multiple years. In 2018, he was named among India’s top scientists by Career 360 and recognized by the USFDA for excellence in GMP practices. His work continues to advance pharmaceutical innovation and global health impact.
Prof. Rath has successfully led numerous national research projects with cumulative funding exceeding ₹22.2 crores from prestigious agencies like NITI Aayog, DBT, DST, AICTE, UGC, and ICMR. He has authored over 250 peer-reviewed publications with a cumulative impact factor of approximately 1080, an h-index of 59, and over 10,800 citations. Additionally, he has contributed to four textbooks, 20 book chapters, and over 60 scientific presentations. His innovative work is protected by 21 patents, six of which have been commercially transferred, generating revenues of ₹37 lakhs. He currently supervises 85 M.Pharm and 10 Ph.D. scholars, and serves on multiple national expert panels in biotechnology and nanomedicine.
